These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20138707)

  • 21. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
    Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
    Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic arsenic poisoning: a global health issue -- a report of multiple primary cancers.
    Walvekar RR; Kane SV; Nadkarni MS; Bagwan IN; Chaukar DA; D'Cruz AK
    J Cutan Pathol; 2007 Feb; 34(2):203-6. PubMed ID: 17244035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential biological mechanisms of arsenic-induced diabetes mellitus.
    Tseng CH
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):67-83. PubMed ID: 15163543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?
    Simeonova PP; Luster MI
    J Environ Pathol Toxicol Oncol; 2000; 19(3):281-6. PubMed ID: 10983894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation.
    Chen H; Liu J; Zhao CQ; Diwan BA; Merrick BA; Waalkes MP
    Toxicol Appl Pharmacol; 2001 Sep; 175(3):260-8. PubMed ID: 11559025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular uptake, subcellular distribution and toxicity of arsenic compounds in methylating and non-methylating cells.
    Dopp E; von Recklinghausen U; Diaz-Bone R; Hirner AV; Rettenmeier AW
    Environ Res; 2010 Jul; 110(5):435-42. PubMed ID: 19758587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of inorganic arsenic on gap junctional intercellular communication between human skin fibroblasts].
    Deng F; Guo X
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Jan; 35(1):51-4. PubMed ID: 11860962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells.
    Dall'Era MA; Oudes A; Martin DB; Liu AY
    Prostate; 2007 May; 67(7):714-21. PubMed ID: 17342744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic in Dermatology.
    Maloney ME
    Dermatol Surg; 1996 Mar; 22(3):301-4. PubMed ID: 8599743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites.
    Kitchin KT
    Toxicol Appl Pharmacol; 2001 May; 172(3):249-61. PubMed ID: 11312654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotoxicology studies of sodium arsenate-effects of exposure on tumor growth and cell-mediated tumor immunity.
    Kerkvliet NI; Steppan LB; Koller LD; Exon JH
    J Environ Pathol Toxicol; 1980 Nov; 4(5-6):65-79. PubMed ID: 7217861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender-specific protective effect of hemoglobin on arsenic-induced skin lesions.
    Breton CV; Houseman EA; Kile ML; Quamruzzaman Q; Rahman M; Mahiuddin G; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):902-7. PubMed ID: 16702368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Children's exposure to arsenic from CCA-treated wooden decks and playground structures.
    Hemond HF; Solo-Gabriele HM
    Risk Anal; 2004 Feb; 24(1):51-64. PubMed ID: 15028000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin.
    Kennedy C; Bajdik CD; Willemze R; Bouwes Bavinck JN
    Br J Dermatol; 2005 Jan; 152(1):194-7. PubMed ID: 15656837
    [No Abstract]   [Full Text] [Related]  

  • 35. [Plasma concentration of selected neoplastic markers in persons occupationally exposed to arsenic and heavy metals].
    Szymańska-Chabowska A; Antonowicz-Juchniewicz J; Andrzejak R
    Med Pr; 2004; 55(4):313-20. PubMed ID: 15620040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphological and functional alterations in human proximal tubular cell line induced by low level inorganic arsenic: evidence for targeting of mitochondria and initiated apoptosis.
    Peraza MA; Cromey DW; Carolus B; Carter DE; Gandolfi AJ
    J Appl Toxicol; 2006; 26(4):356-67. PubMed ID: 16773642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemical and physical cutaneous carcinogenesis (excluding UV)].
    Dereure O; Guillot B
    Ann Dermatol Venereol; 2004 Mar; 131(3):299-306. PubMed ID: 15107756
    [No Abstract]   [Full Text] [Related]  

  • 38. Arsenic exposure and the induction of human cancers.
    Martinez VD; Vucic EA; Becker-Santos DD; Gil L; Lam WL
    J Toxicol; 2011; 2011():431287. PubMed ID: 22174709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hazards of inorganic arsenic.
    Nurse DS
    Med J Aust; 1978 Jan; 1(2):102. PubMed ID: 651699
    [No Abstract]   [Full Text] [Related]  

  • 40. Cutaneous metastases from renal neoplasms.
    SCORER CG
    Br J Urol; 1951 Sep; 23(3):250-62. PubMed ID: 14879017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.